Reitmans (Canada) Limited (RET-A)
TSX Venture Exchange · Canada · prices in CAD · close of 22 Oct 2026
Key indicators
| Last close | CAD 2.050 |
|---|---|
| 52-week range | 1.800 – 2.480 |
| Return, 1 month / 3 months | −1.4% / +2.5% |
| Return, 1 year / 3 years | +0.0% / −8.1% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 46 |
| Volatility (1 year) | 33.5% |
| Worst drawdown (1 year) | -24.2% |
| Average daily value traded | 0.05M CAD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Reitmans (Canada) Limited is a Canadian specialty retailer of women's apparel. The company designs and sells clothing through its own chain of stores and related online shops, serving customers across Canada with everyday fashion, workwear and occasion wear. Its banners address different fits and styles, including plus-size and petite ranges, and the business is based in Canada, where it runs its retail operations and distribution.
Reitmans (Canada) Limited trades under the code RET-A on the TSX Venture Exchange in Canada, with its price quoted in Canadian dollars (CAD). Our dividend records, which start in 2019, show payments in one calendar year. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Reitmans (Canada) Limited (RET-A) trades on the TSX Venture Exchange in Canada. It last closed at CAD 2.050 on 22 October 2026.
Its price-based Market X-Ray is 82 out of 100 (a strong price profile), ranking 65 of 1,501 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 0.0% and over the last three months it rose 2.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on TSX Venture Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 81 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 1.0% | ||
| From 52-week high | -14.6% | ||
| Momentum | 72 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 2.5% | ||
| 6-month return | 2.0% | ||
| 12-month return, skipping the last month | 1.5% | ||
| Stability (higher is calmer) | 92 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.2% | ||
| Liquidity | 81 · Strong | Trades actively. | |
| Average daily value traded | 0.05M CAD | ||
| Zero-volume days | 3.3% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 0 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.8% |
|---|---|
| 1 month | −1.4% |
| 3 months | +2.5% |
| 6 months | +2.0% |
| 1 year | +0.0% |
| 3 years | −8.1% |
| 5 years | +78.3% |
Signals
| 50-day / 200-day average | 2.065 / 2.030 |
|---|---|
| Golden / death cross (60 days) | Golden, 19 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.053 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 9 Oct 2019 | CAD 0.0500 |
| 10 Jul 2019 | CAD 0.0500 |
| 12 Apr 2019 | CAD 0.0500 |
| 11 Jan 2019 | CAD 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on TSX Venture Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.